A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes
Cancer Cell2006Vol. 10(6), pp. 515–527
Citations Over TimeTop 1% of 2006 papers
Richard M. Neve, Koei Chin, Jane Fridlyand, Jennifer Yeh, Frederick L. Baehner, Tea Fevr, Laura Ashley Clark, Nora Bayani, Jean‐Philippe Coppé, Frances Tong, Terence P. Speed, Paul T. Spellman, Sandy DeVries, Anna Lapuk, N. Wang, Wen‐Lin Kuo, Jackie L. Stilwell, Daniel Pinkel, Donna G. Albertson, Frederic M. Waldman, Frank McCormick, Robert B. Dickson, Michael D. Johnson, Marc E. Lippman, Stephen P. Ethier, Adi F. Gazdar, Joe W. Gray
Related Papers
- → Mechanisms of Trastuzumab Resistance and Their Clinical Implications(2005)74 cited
- → Intravenous and subcutaneous formulations of trastuzumab, and trastuzumab biosimilars: implications for clinical practice(2021)37 cited
- → Is there any cumulative dose for trastuzumab?(2014)3 cited
- → Cytotoxic Effects of Seleno-Trastuzumab, Trastuzumab (Herceptin) and T-DM-1 (Kadcyla) on Trastuzumab Resistant JIMT-1 Breast Cancer Cells(2014)
- Cardiac toxicity of trastuzumab in elderly patients with breast cancer(2016)